How Can Polymorph Patents Increase Cost Efficiency?

Pharma IQ

Mandar Kodgule, Head of Intellectual Property and Strategic Planning at Wockhardt, answers this question as well as offering the top five strategic considerations to sustain a healthy polymorph patent portfolio and to create polymorphic wealth. In this interview with Helen Winsor from Pharma IQ, he also touches upon how the regulatory landscape is changing and what impact it is having on enforceability of polymorph patents. Kodgule also addresses the issue of excessive innovation...
To continue reading this story

Learn More   Existing Users